Can you provide the last earnings date for TENAYA THERAPEUTICS INC?
TENAYA THERAPEUTICS INC (TNYA) last reported earnings on 3/11/2026.
NASDAQ:TNYA • US87990A1060
Past quarterly earnings results for TENAYA THERAPEUTICS INC (TNYA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.12 | -0.12 | 2.97% | 57.14% | - | - | ||
| Q3 2025 | -0.12 | -0.15 | 20.39% | 60.00% | - | - | ||
| Q2 2025 | -0.14 | -0.26 | 45.10% | 58.82% | - | - | ||
| Q1 2025 | -0.24 | -0.19 | -23.84% | 40.00% | - | - | ||
| Q4 2024 | -0.28 | -0.32 | 11.76% | 30.00% | - | - | ||
| Q3 2024 | -0.30 | -0.37 | 19.97% | 23.08% | - | - | ||
| Q2 2024 | -0.34 | -0.40 | 14.77% | 24.44% | - | - | ||
| Q1 2024 | -0.40 | -0.43 | 7.26% | 6.98% | - | - | ||
| Q4 2023 | -0.40 | -0.45 | 10.62% | 34.43% | - | - | ||
| Q3 2023 | -0.39 | -0.48 | 19.14% | 47.30% | - | - | ||
| Q2 2023 | -0.45 | -0.51 | 12.35% | 34.78% | - | - | ||
| Q1 2023 | -0.43 | -0.57 | 25.16% | 42.67% | - | - | ||
| Q4 2022 | -0.61 | -0.66 | 7.99% | 3.17% | - | - | ||
| Q3 2022 | -0.74 | -0.65 | -13.06% | -8.82% | - | - | ||
| Q2 2022 | -0.69 | -0.77 | 10.76% | 94.80% | - | - | ||
| Q1 2022 | -0.75 | -0.66 | -14.00% | - | - | - | ||
| Q4 2021 | -0.63 | -0.62 | -2.09% | - | - | - | ||
| Q3 2021 | -0.68 | -0.72 | 5.44% | - | - | - | ||
| Q2 2021 | -13.26 | -7.32 | -81.18% | - | - | - | ||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
TENAYA THERAPEUTICS INC (TNYA) last reported earnings on 3/11/2026.
TENAYA THERAPEUTICS INC (TNYA) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, TENAYA THERAPEUTICS INC (TNYA) has beaten EPS estimates in 3 out of 4 releases.